Comparative Effectiveness Research:
Do Employers Care? What Will They Do?
ChuCk Reynolds, Ms,
President, Employer Practice
diana MaRtin,
Senior Consultantboth o The Beneld Group
RobeRt W. dubois, Md, Pd,
Chie Science Ocer
kiMbeRly WestRiCh, Ma,
Research Directorboth o the National Pharmaceutical Council
A White Paper Prepared For NPC By
June 2011
Written by:
ChuCk Reynolds, Ms,
President, Employer Practice
diana MaRtin,
Senior Consultantboth o The Beneld Group
RobeRt W. dubois, Md, Pd,
Chie Science Ocer
kiMbeRly WestRiCh, Ma,
Research Directorboth o the National Pharmaceutical CouncilThe
Benfeld Group
is a health care market research, strategy and communications rm dedicatedto improving health care value through meaningul inormation, clear communication and innovativecollaboration along the health care supply chain. The
National Pharmaceutical Council
is a health policy research organization dedicated to theadvancement o good evidence and science, and to ostering an environment in the United States thatsupports medical innovation. Founded in 1953 and supported by the nation’s major research-basedpharmaceutical companies, NPC ocuses on research development, inormation dissemination, andeducation on the critical issues o evidence, innovation and the value o medicines or patients.
Acknowledgments:
The authors would like to acknowledge Diana Enyedi, Jennier Graf, AndreaHoelich, Gary Persinger, and Sabrina Siddiqui or their thoughtul contributions to this report.
Funded and published by
the National Pharmaceutical Council, 2011.To order copies o this report, please visit www.npcnow.org.© Copyright 2011
AbstrAct
Recent Federal legislation, including the Patient Protection and Aordable Care Act(ACA), has launched a comprehensive national eort to conduct and disseminatecomparative eectiveness research (CER). As purchasers o health care oremployees, dependents and retirees, employers stand to benet rom potentialquality and cost impacts o CER. Further, because they can inuence patients,providers and provider organizations through health programs and benet design,employers have the ability to contribute to the translation o CER ndings intoclinical practice, enabling quality and cost improvements.Our research indicates that a sizable segment o employers (specically, largeand sel-insured employers who comprised our sample) are aware o CER andexpect that CER ndings will help them achieve health improvement and costmanagement goals. These employers have clear ideas about how they would usehealth programs and benet strategies to help translate CER ndings into practice.Our research urther indicates that employers would value CER outcomes related to workorce productivity, and believe it is important or CER research to consider theimpact o alternative treatments on absence, disability and work perormance whenappropriate. The Patient-Centered Outcomes Research Institute (PCORI) is by aremployers’ most trusted source o CER inormation; and while some employers planto directly monitor CER developments, most will rely on their health plans, consultantsand Pharmacy Benet Managers (PBMs) to keep them apprised o relevant mattersand to help identiy and implement eective program and policy actions.Employers are important health care stakeholders, and–particularly i ndingsaddress their interests in workorce productivity as well as employee health andhealth care costs–employers will be an ally in the eort to translate CER ndingsinto better clinical practice, improved health, enhanced productivity and lower costs.
1
Search History:
Result 00 of 00
00 results for result for
p.
Comparative Effectiveness Research: Do Employers Care? What Will They Do?
On behalf of the National Pharmaceutical Council, the Benfield Group conducted a survey in December 2010 to assess the attitudes of employers on comparative effectiveness research (CER).
Key Findings:
Employers know about CER
Employers care about… (More)
Key Findings:
Employers know about CER
Employers care about… (More)
2.1K
Reads
1
Readcasts
0
Embed Views
More From This User
Notes
Load more
